Ignite Creation Date:
2024-05-06 @ 7:01 PM
Last Modification Date:
2024-10-26 @ 2:58 PM
Study NCT ID:
NCT05863364
Status:
RECRUITING
Last Update Posted:
2023-08-08
First Post:
2022-12-28
Brief Title:
Rifaximin for Preventing Progression and Complications in Patients With Decompensated Liver Cirrhosis
Sponsor:
Xin Zeng
Organization:
Shanghai East Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-08-18
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2022-12-28
First Submit QC Date:
May 16 2023
Study First Post Date:
2023-05-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-05
Last Update Post Date:
2023-08-08
Last Update Post Date Type:
ACTUAL